Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: J Pain. 2019 May 23;21(1-2):2–24. doi: 10.1016/j.jpain.2019.05.008

Table 3:

Results of the meta-analysis: genetic models

Gene SNP Reference Alleles Number of Studies Genetic model Effect size Heterogeneity
OR 95% CI p-value I2 (%) pQ
OPRM1 rs1799971 G (minor) 5 (T, Ko, M, Ka, H) dominant 1.052 (0.856, 1.294) 0.630 0 0.669
GCH1 rs3783641 A (minor) 3 (B, M, H) additive 1.123 (0.908, 1.390) 0.285 60.7 0.079
COMT rs4680 A (minor) 5 (Hi, T, Ko, M, H) additive 1.012 (0.855, 1.198) 0.888 65.9 0.019
COMT rs4680 A (minor) dominant 1.028 (0.862, 1.228) 0.757 50.9 0.086
COMT rs4680 A (minor) recessive 1.058 (0.884, 1.264) 0.541 64.0 0.025
COMT rs6269 G (minor) 2 (B, M) additive 0.993 (0.845, 1.169) 0.935 79.7 0.026
KCNS1 rs734784 G (minor) 2 (L, C) additive 1.511 (1.000, 2.284) 0.050 0 0.344
TNF-alpha/TNFA rs1800629 G (major) 2 (M, Ka) allelic 1.240 (0.963, 1.597) 0.096 73.2 0.054

I2: ratio of excess heterogeneity (observed total variation – expected variation) to total variation in observed effects; OR: odds ratio; CI: confidence interval

pQ: p-value of the Q statistics, weighted sum of squares of the deviation of each observed effect size from the mean effect size.

T: Thomazeau 2016, Ko: Kolesnikov 2013, M: Montes 2015, Ka: Kaliomaki 2016; H: Hegarty 2012, Hi: Hickey 2011; B: Belfer 2015; L: Langford 2015, C: Costigan 2010.